Access Control Flaw in IBM Aspera Faspex Affects Multiple Versions
CVE-2023-37412

4.9MEDIUM

Key Information:

Vendor

IBM
Status
Aspera Faspex
Vendor
CVE Published:
29 January 2025

What is CVE-2023-37412?

An access control vulnerability in IBM Aspera Faspex versions 5.0.0 through 5.0.10 may enable a privileged user to execute unauthorized system changes, bypassing established access controls. This can lead to significant security risks as systems may be altered without the necessary oversight or permissions.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Aspera Faspex 5.0.0 <= 5.0.10

References

https://www.ibm.com/support/pages/node/7181814

CVSS V3.1

Score:
4.9
Severity:
MEDIUM
Confidentiality:
None
Integrity:
High
Availability:
None
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
High
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.